These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9728551

  • 1. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor.
    Draper D, Donohoe W, Mortimer L, Heine RP.
    J Infect Dis; 1998 Sep; 178(3):815-9. PubMed ID: 9728551
    [Abstract] [Full Text] [Related]

  • 2. Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.
    Huppert JS, Huang B, Chen C, Dawood HY, Fichorova RN.
    J Infect Dis; 2013 May 01; 207(9):1462-70. PubMed ID: 23355743
    [Abstract] [Full Text] [Related]

  • 3. Trichocystatin-2 (TC-2): an endogenous inhibitor of cysteine proteinases in Trichomonas vaginalis is associated with TvCP39.
    Puente-Rivera J, Ramón-Luing Lde L, Figueroa-Angulo EE, Ortega-López J, Arroyo R.
    Int J Biochem Cell Biol; 2014 Sep 01; 54():255-65. PubMed ID: 25200185
    [Abstract] [Full Text] [Related]

  • 4. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
    Wahl SM, McNeely TB, Janoff EN, Shugars D, Worley P, Tucker C, Orenstein JM.
    Oral Dis; 1997 May 01; 3 Suppl 1():S64-9. PubMed ID: 9456660
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
    Rao NV, Marshall BC, Gray BH, Hoidal JR.
    Am J Respir Cell Mol Biol; 1993 Jun 01; 8(6):612-6. PubMed ID: 8100709
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S, van der Linden AC, van Sterkenburg MA, Rabe KF, Schalkwijk J, Hiemstra PS.
    J Investig Med; 2000 Sep 01; 48(5):359-66. PubMed ID: 10979241
    [Abstract] [Full Text] [Related]

  • 9. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM.
    J Clin Invest; 1995 Jul 01; 96(1):456-64. PubMed ID: 7615818
    [Abstract] [Full Text] [Related]

  • 10. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
    Turpin JA, Schaeffer CA, Bu M, Graham L, Buckheit RW, Clanton D, Rice WG.
    Antiviral Res; 1996 Mar 01; 29(2-3):269-77. PubMed ID: 8739605
    [Abstract] [Full Text] [Related]

  • 11. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.
    Farquhar C, VanCott TC, Mbori-Ngacha DA, Horani L, Bosire RK, Kreiss JK, Richardson BA, John-Stewart GC.
    J Infect Dis; 2002 Oct 15; 186(8):1173-6. PubMed ID: 12355371
    [Abstract] [Full Text] [Related]

  • 12. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM, Worley P, Jin W, McNeely TB, Eisenberg S, Fasching C, Orenstein JM, Janoff EN.
    Am J Pathol; 1997 Apr 15; 150(4):1275-84. PubMed ID: 9094984
    [Abstract] [Full Text] [Related]

  • 13. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C, Shimizu T, Sato K, Ogasawara K, Tomioka H.
    Kekkaku; 1999 Jul 15; 74(7):563-70. PubMed ID: 10481411
    [Abstract] [Full Text] [Related]

  • 14. Uterine-associated serine protease inhibitors stimulate deoxyribonucleic acid synthesis in porcine endometrial glandular epithelial cells of pregnancy.
    Badinga L, Michel FJ, Simmen RC.
    Biol Reprod; 1999 Aug 15; 61(2):380-7. PubMed ID: 10411515
    [Abstract] [Full Text] [Related]

  • 15. Polyamine depletion down-regulates expression of the Trichomonas vaginalis cytotoxic CP65, a 65-kDa cysteine proteinase involved in cellular damage.
    Alvarez-Sánchez ME, Carvajal-Gamez BI, Solano-González E, Martínez-Benitez M, Garcia AF, Alderete JF, Arroyo R.
    Int J Biochem Cell Biol; 2008 Aug 15; 40(11):2442-51. PubMed ID: 18586550
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD, Kennedy JA, Zitnik RJ, Kashem MA.
    Biochem Biophys Res Commun; 1999 Jan 27; 254(3):614-7. PubMed ID: 9920787
    [Abstract] [Full Text] [Related]

  • 17. The elimination of secretory leukocyte protease inhibitor (SLPI) from the gastrointestinal tract in man.
    Nyström M, Bergenfeldt M, Ohlsson K.
    Scand J Clin Lab Invest; 1997 Apr 27; 57(2):119-25. PubMed ID: 9200270
    [Abstract] [Full Text] [Related]

  • 18. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma.
    Fath MA, Wu X, Hileman RE, Linhardt RJ, Kashem MA, Nelson RM, Wright CD, Abraham WM.
    J Biol Chem; 1998 May 29; 273(22):13563-9. PubMed ID: 9593692
    [Abstract] [Full Text] [Related]

  • 19. Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.
    Taggart CC, Greene CM, McElvaney NG, O'Neill S.
    J Biol Chem; 2002 Sep 13; 277(37):33648-53. PubMed ID: 12084717
    [Abstract] [Full Text] [Related]

  • 20. Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa.
    Bergenfeldt M, Nyström M, Bohe M, Lindström C, Polling A, Ohlsson K.
    J Gastroenterol; 1996 Feb 13; 31(1):18-23. PubMed ID: 8808424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.